Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 9/20 | 0.73 |
| ▸ | CA2 | P00918 | 9/20 | 0.73 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.73 |
| ▸ | CA9 | Q16790 | 7/20 | 0.62 |
| ▸ | CA12 | O43570 | 6/20 | 0.62 |
| ▸ | CA4 | P22748 | 3/20 | 0.57 |
| ▸ | PDE4A | P27815 | 1/20 | 0.55 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.55 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.55 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL499993 | 1.00 | CA1 (0.73) | CA1CA2PDE3ACA9CA12 | |
| SCHEMBL19171231 | 0.85 | CA1 (1.00) | CA1CA2PDE3ACA9CA12 | |
| Tavaborole SCHEMBL500016 | 0.85 | CA1 (1.00) | CA1CA2PDE3ACA9CA12 | |
| Tavaborole SCHEMBL29372574 | 0.85 | CA1 (1.00) | CA1CA2PDE3ACA9CA12 | |
| Tavaborole SCHEMBL596052 | 0.85 | CA1 (1.00) | CA1CA2PDE3ACA9CA12 | |
| SCHEMBL596283 | 0.82 | CA1 (0.56) | CA1CA2PDE3ACA9CA12 | |
| SCHEMBL23219874 | 0.81 | CA1 (0.58) | CA1CA2PDE3ACA9CA12 | |
| SCHEMBL1135328 | 0.78 | CA1 (0.65) | CA1CA2CA9CA12CA4 | |
| SCHEMBL12875317 | 0.77 | CA1 (1.00) | CA1CA2CA9CA12CA4 | |
| SCHEMBL13983651 | 0.77 | CA1 (0.62) | CA1CA2CA9CA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070155699-A1 | Boron-containing small molecules | ANACOR PHARMACEUTICALS (US) | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070155699-A1 | Boron-containing small molecules | ETF1, POLR1C, DPM1 | CA1 4091/4885CA2 1368/4885PDE3A 4505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.